342
Participants
Start Date
January 4, 2016
Primary Completion Date
October 28, 2020
Study Completion Date
October 26, 2021
Selinexor
Selinexor 60mg
Placebo
UZ Brussel, Brussels
UCL Saint-Luc, Brussels
UZ Gent, Ghent
Columbia University Medical Center, New York
Candiolo Cancer Institute, Candiolo
Memorial Sloan Kettering Cancer Center, New York
Northwell Health Physicians Partners, New York
Helios Hospital Berlin-Buch, Berlin
Timone University Hospital, Marseille
University of Pittsburgh Medical Center (UPMC), Pittsburgh
University of Pennsylvania, Philadelphia
Fox Chase Cancer Center, Philadelphia
Istituto Nazionale dei Tumori, Milan, Milan
Johns Hopkins, Baltimore
Duke Institute of Cancer, Durham
Hospital Universitario Clínico San Carlos, Madrid
Institut Claudius Regaud, Toulouse
Mayo Clinic, Jacksonville
Institut Bergonie, Bordeaux
Institut Régional du Cancer de Montpellier (ICM), Montpellier
Vanderbilt, Nashville
"Germans Trias Pujol University Hospital", Badalona
Hospital Universitario Virgen Del Rocio, Seville
Hospital La Fe Valencia, Valencia
University of Michigan, Ann Arbor
Sheba Medical Center, Ramat Gan
Mayo Clinic Rochester, Rochester
Oscar Lambret Center, Lille
Northwestern Memorial Hospital, Chicago
Washington University School of Medicine, St Louis
Tel Aviv Sourasky Medical, Tel Aviv
University Hospital Mannheim, Mannheim
National Center for Tumor Diseases, Univeristy Hospital Heidelberg, Heidelberg
Institut Curie, Paris
MD Anderson, Houston
University of Colorado-Denver, Denver
Klinik und Poliklinik für Innere Medizin III, Hämatologie und Onkologie Klinikum rechts der Isar der TU Muenchen, München
Soroka University Medical Center, Beersheba
Cedars-Sinai Medical Center, Los Angeles
University of California, Los Angeles, Los Angeles
U.O.C. Oncologia Medica Oncology Department, Palermo
Sarcoma Oncology Center, Santa Monica
Hadassah Medical Center, Jerusalem
Institut Gustave Roussy, Villejuif
Stanford University, Stanford
Centre Leon Berard, Lyon
Oregon Health and Science, Portland
Fred Hutchinson Cancer Research Center, Seattle
Rabin Medical Center, Petah Tikva
Assaf Harofe Medical Center, Ẕerifin
Yale Cancer Center, New Haven
Massachusetts General Hospital, Boston
Dana Farber Cancer Institute, Boston
James Cancer Center, Ohio State University, Columbus
Cross Cancer Center - Alberta Health Services, Edmonton
The Ottawa Hospital Cancer, Ottawa
Princess Margaret Hospital, Toronto
McGill University, Montreal
CLCC Antoine Lacassagne, Nice
Technische Universitaet Dresden Med. Fakultaet Carl Gustav Carus Med. Klinik u. Poliklinik I, Dresden
Policlinico Universitario Campus Biomedico, Roma
Vall d´hebron University Hospital, Barcelona
Hospital Sant Pau Barcelona, Barcelona
Hospital ICO Bellvitge, Barcelona
Sahlgrenska Universitetssjukhuset, Gothenburg
Skane University Hospital, Lund
Onkologiska Kliniken, Stockholm
Cambridge University Hospitals NHS Foundation Trust, Cambridge
University College London Hospitals, London
The Royal Marsden NHS Foundation Trust, London
The Christie, Manchester
Lead Sponsor
Karyopharm Therapeutics Inc
INDUSTRY